1,011 to 1,020 of 1,630 Results
Adobe PDF - 10.4 MB -
MD5: 6224fe3bbbe729becf6dbad3c0c76b47
Termos de audiência de custódia pesquisados |
Alves, Gabriele Cardoso Gonçalves; Amador, Fabiola Leticia Damascena; Santos, Vagner Rogério; Moreira, Rita Simone Lopes, 2024, "Data for: REBEn-2023-0491: Desenvolvimento e validação do protótipo de um aplicativo móvel para pós-operatório de cirurgia cardíaca", https://doi.org/10.48331/scielodata.ILIRZR, SciELO Data, V1
Os dados presentes no documento são de um estudo de desenvolvimento e validação do protótipo de um aplicativo para acompanhamento de pacientes em pós-operatório de cirurgia cardíaca. O recorte de dados envidados neste documento envolve: (I) Tabela 1 - Critérios de seleção dos jur... |
Jun 27, 2024 -
Data for: REBEn-2023-0491: Desenvolvimento e validação do protótipo de um aplicativo móvel para pós-operatório de cirurgia cardíaca
Adobe PDF - 4.4 MB -
MD5: a217436352a17565fade3588863d7b1e
(I) Quadro 1 - Critérios de seleção dos jurados especialistas;
(II) Tabela 1 - Caracterização dos jurados especialistas;
(III) Quadro 2 - Comentários dos jurados especialistas;
(IV) Tabela 2 - Razão de Validade de Conteúdo das telas do aplicativo por meio do IVCES;
(V) Tabela 3... |
|
Jun 27, 2024 -
Data for: REBEn-2023-0491: Desenvolvimento e validação do protótipo de um aplicativo móvel para pós-operatório de cirurgia cardíaca
Adobe PDF - 63.0 KB -
MD5: 48a60d7647a44b5aefca1b8ed65f79c5
Detalhamento do estudo |
Patntirapong, Somying; Champakerdsap, Chunya; Mathaveechotikul, Pichaya; Vatanasilp, Apichaya, 2024, "Replication Data for: Improvement of osteoblast adhesion, viability, and mineralization via restoring cell cytoskeleton after bisphosphonate discontinuation in vitro", https://doi.org/10.48331/scielodata.G7NCSX, SciELO Data, V1, UNF:6:TzhLckb/KHUlQ3pudtqQjw== [fileUNF]
Introduction: Bisphosphonate is prescribed to treat excessive bone resorption in osteoporotic patients. However, its use is associated with potential adverse effects such as medication-related osteonecrosis of the jaw, prompting the introduction of the drug holiday concept in pat... |
JPEG Image - 274.7 KB -
MD5: 0c6deb9dddc0be89f18b5c022e3aa656
Cell viability of pre-osteoblasts and osteoblasts after ALN treatment and discontinuation at various time points. MC3T3 cells were incubated with 1, 5, and 10 µM ALN (A1, A5, and A10). Negative control was abbreviated as A0. The “S” was abbreviated for stoppage of ALN. N = 4 |
JPEG Image - 259.7 KB -
MD5: 14c1d924432c6f3bc3f4f925dec34bea
Examination of osteoblast nodule formation and viability. Osteoblasts were incubated with 1, 5, and 10 µM ALN (A1, A5, and A10). (A) Micrographs demonstrate nodule formation after treatment and cessation of ALN. (B) Quantification of alizarin red-positive area (mm2). (C) Quantifi... |
JPEG Image - 137.6 KB -
MD5: dfe16c2f3ff21028ab9d438dc2ff9407
Evaluation of viable cells. (A) Micrographs of pre-osteoblast depicting cell morphology. (B) Number of live cells after 7-day cell culture. (C) Percent of dead cells after 7-day cell culture. Arrowhead indicated round cells. Scale bar = 100 µm. N = 4 |
JPEG Image - 320.9 KB -
MD5: dd73b40a86ddb058708dfb9104c6f351
Investigation of cell adhesion after treatment and cessation of ALN. (A) Confocal images of nuclei and cell cytoskeleton. (B) Number of DAPI/field. (C) Stress fiber intensity. (D) Stress fiber density. (E) Cell area (µm2). (F) Cell perimeter. (G) Area/perimeter (A/P). (H) Aspect... |
JPEG Image - 307.7 KB -
MD5: efad4e6fcdde9135af7d70052c30cc92
Gene expressions. Two conditions of treatment and cessation were investigated. Gr 1: Tx1d S1d, Gr 9: Tx4d S3d. Dashed lines are mRNA expressions of A0. N = 3 |
